| Y/e 31 Mar | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 | 
|---|---|---|---|---|
Growth matrix (%)  | ||||
Revenue growth  | 15.61  | 11.66  | 21.73  | 7.18  | 
Op profit growth  | -6.93  | 46.13  | 3.78  | -4.14  | 
EBIT growth  | 1.23  | 33.63  | 9.12  | -4.09  | 
Net profit growth  | 8.99  | 39.8  | -0.2  | -7.53  | 
Profitability ratios (%)  | ||||
OPM  | 27.81  | 34.55  | 26.4  | 30.97  | 
EBIT margin  | 27.52  | 31.43  | 26.26  | 29.3  | 
Net profit margin  | 21.33  | 22.62  | 18.07  | 22.04  | 
RoCE  | 28.1  | 30.82  | 27.88  | 33.49  | 
RoNW  | 5.69  | 5.84  | 5.03  | 6.49  | 
RoA  | 5.44  | 5.54  | 4.79  | 6.29  | 
Per share ratios (₹)  | ||||
EPS  | 83.01  | 75.2  | 53.33  | 52.98  | 
Dividend per share  | 9.5  | 9.5  | 13  | 0  | 
Cash EPS  | 68.15  | 61.6  | 42.25  | 46.07  | 
Book value per share  | 378.77  | 343.14  | 295.23  | 229.95  | 
Valuation ratios  | ||||
P/E  | 14.52  | 15.89  | 17.07  | 17.68  | 
P/CEPS  | 17.69  | 19.4  | 21.55  | 20.33  | 
P/B  | 3.18  | 3.48  | 3.08  | 4.07  | 
EV/EBIDTA  | 14.6  | 14.97  | 15.2  | 17.99  | 
Payout (%)  | ||||
Dividend payout  | 11.53  | 12.67  | 24.78  | 0  | 
Tax payout  | -21.63  | -27.36  | -29.38  | -24.72  | 
Liquidity ratios  | ||||
Debtor days  | 96.04  | 95.6  | 87.1  | 67.21  | 
Inventory days  | 85.07  | 79.71  | 59.68  | 48.21  | 
Creditor days  | -59.26  | -78.95  | -66.05  | -60.65  | 
Leverage ratios  | ||||
Interest coverage  | -90.16  | -109.84  | -57.07  | -1,519.41  | 
Net debt / equity  | -0.05  | -0.05  | -0.05  | -0.04  | 
Net debt / op. profit  | -0.2  | -0.17  | -0.19  | -0.13  | 
Cost breakup (₹)  | ||||
Material costs  | -24.91  | -22.32  | -25.33  | -19.11  | 
Employee costs  | -19.32  | -18.97  | -18.76  | -17.7  | 
Other costs  | -27.94  | -24.14  | -29.49  | -32.19  | 
Ajanta Pharma reported a strong EBITDA margin of 25% in the quarter.
 IIFL Customer Care Number 
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000  / 7039-050-000
 IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.